Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Cronos Australia Ltd. ( (AU:VIT) ).
Vitura Health Limited has lodged its amended company constitution with the ASX, formalising changes approved by shareholders at the company’s 26 November 2025 Annual General Meeting, after a delay attributed to an administrative oversight. While the filing itself is procedural, it completes the governance step endorsed by investors and underscores the company’s efforts to align its corporate framework with its evolving digital health and medicinal products platform, which spans medicinal cannabis distribution, telehealth services, and a growing foothold in regulated psychedelic therapies, potentially strengthening its position in Australia’s rapidly developing digital and specialty healthcare markets.
The most recent analyst rating on (AU:VIT) stock is a Hold with a A$0.07 price target. To see the full list of analyst forecasts on Cronos Australia Ltd. stock, see the AU:VIT Stock Forecast page.
More about Cronos Australia Ltd.
Vitura Health Limited is an ASX-listed diversified digital health business focused on medicinal cannabis distribution, telehealth services and emerging psychedelic therapies in Australia. Through subsidiaries including Burleigh Heads Cannabis and its Canview platform, the company operates a leading online ecosystem connecting prescribers, patients, pharmacies and suppliers for more than 430 therapeutic products and devices from around 60 domestic and international brands. Vitura also owns the 24/7 telehealth provider Doctors on Demand, medicinal cannabis clinics CDA Clinics and Cannadoc, and holds a 50% stake in Cortexa, a joint venture with PharmAla Biotech aimed at supplying GMP-grade MDMA and psilocybin for research and therapeutic use, supported by licensed distribution centres in Melbourne and the Gold Coast capable of handling a broad range of scheduled medicines.
Average Trading Volume: 256,348
Technical Sentiment Signal: Sell
Current Market Cap: A$41.09M
Find detailed analytics on VIT stock on TipRanks’ Stock Analysis page.